GlassScriptPhysician profile
Michael B Polsky
NPI 1992816706
$98,715.20
in general payments reported to CMS, 2019-2025
39 companies · $78K in 2025
The $78K reported for 2025 was more than what 98% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $323 · 2021: $1,207 · 2022: $3,938 · 2023: $3,146 · 2024: $11K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Honoraria: $18K · Travel and Lodging: $13K · Food and Beverage: $13K · Education: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,450.00 |
| Honoraria | $18,000.00 |
| Travel and Lodging | $13,082.38 |
| Food and Beverage | $12,623.65 |
| Education | $318.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $88,831.58 | 2019-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $3,212.08 | 2019-2025 | Xywav |
| Astrazeneca Pharmaceuticals LP | $1,126.87 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $981.04 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $830.68 | 2020-2025 | Wakix |
| Philips North America LLC | $403.92 | 2019-2024 | (Ak6) Vest Therapy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $348.99 | 2019-2024 | Ofev |
| Axsome Therapeutics, INC. | $307.47 | 2023-2025 | Sunosi |
| Amgen INC. | $266.10 | 2022-2025 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $263.55 | 2023-2025 | Lumryz |
| Genzyme Corporation | $229.85 | 2019-2025 | |
| Baxter Healthcare | $212.71 | 2022-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $161.12 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $154.77 | 2019-2025 | Xolair |
| Grifols USA, LLC | $145.69 | 2020-2024 | Prolastin-C Liquid, Xembify |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $121.37 | 2022-2024 | |
| Mylan Specialty L.P. | $116.24 | 2021-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $105.08 | 2021-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $98.08 | 2021-2023 | Acthar |
| Lilly USA, LLC | $89.46 | 2025 | Zepbound |
| Ani Pharmaceuticals, INC. | $64.89 | 2024 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $59.45 | 2022-2024 | Tyvaso |
| Ensodata, INC. | $53.12 | 2025 | |
| Verona Pharma, INC. | $50.07 | 2025 | Ohtuvayre |
| Electromed, INC. | $49.85 | 2022-2024 | Smartvest |
| Insmed, INC. | $46.25 | 2019-2025 | Arikayce |
| Resmed Corp | $45.66 | 2019-2021 | |
| Intuitive Surgical, INC. | $44.23 | 2021 | |
| Vanda Pharmaceuticals INC. | $37.69 | 2019-2020 | |
| Atricure, INC. | $34.16 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Arbor Pharmaceuticals, INC. | $31.80 | 2021 | |
| Pharming Healthcare, INC. | $29.76 | 2022-2023 | Ruconest |
| Biogen, INC. | $27.01 | 2025 | Skyclarys |
| Circassia INC. | $24.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.75 | 2019 | |
| Pulmonx Corporation | $23.38 | 2023 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| 3b Medical, INC. | $22.29 | 2025 | Luna |
| Paratek Pharmaceuticals, INC. | $20.86 | 2022 | |
| Tactile Systems Technology INC | $20.04 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Polsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.